358P Everolimus or ribociclib in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and circulating tumor cells: Results from DETECT IVa
| Autor: | Fehm, T.N., Schochter, F., Rack, B., Wimberger, P., Paluchowski, M. Banys, Neubauer, H., Wiesmueller, L., Meier-Stiegen, F., Fasching, P.A., Blohmer, J-U., Hartkopf, A.D., Heublein, S., Huober, J., Riethdorf, S., Pantel, K., Schneeweiss, A., Friedl, T.W.P., Mueller, V., Janni, W. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S367-S367 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|